Users Discontinuing Weight-Loss Medications Gain Back Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis suggests that individuals who discontinue new GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds far faster than those who end traditional lifestyle regimens.

Findings released in a leading medical journal demonstrates that while overweight individuals frequently drop substantial amounts of their body weight while using the jabs, the mass returns at an estimated rate of 0.8 kg per month once they quit.

"People purchasing these medications should be cognizant of the risk of fast weight regain when the therapy is stopped," warns researcher Dr. Susan Jebb.

That rate of regain suggests a return to original mass within about a year and a half.

Analyzing Therapies

The analysis, which looked at 37 of studies involving over 9,000 of patients, contrasted the effects of the injectable medications with older methods.

The team note that people who lose weight through dieting typically experience a slower weight regain—perhaps 0.1 kg a month—after stopping.

Explaining the Fast Rebound

Nutrition scientists suggest the mode of action of the injections is key to understanding the accelerated weight return.

These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Artificially providing GLP-1 levels several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication results in hunger is uncontrolled, making overeating far more likely."

A Lifelong Issue?

The NHS recommend the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.

Many experts contend that, given the high risk of relapse, the therapy is often long-term.

This opinion is supported by pharmaceutical companies, who say that the results "emphasize the long-term nature of excess weight," similar to managing diseases like high blood pressure.

User Testimonies

People who have come off the jabs explain a sudden return of cravings.

"It was like a switch activating and I was suddenly starving," described an individual.

This difficulty is exacerbated if users have not established sustainable lifestyle or habit modifications during therapy.

Widespread Adoption

Survey data indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.

• Adoption is greater among women than males.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion access the medications through private prescriptions rather than the NHS.

Finally, experts stress that while GLP-1 drugs are potent tools for weight loss, they are not a permanent solution and maintained weight loss relies on integrated lifestyle management.